Product image of Miorel (Thiocolchicoside) supplied by GNH India

Miorel

Active Ingredient:
Thiocolchicoside
Origin:
EU

Miorel (Thiocolchicoside)

Thiocolchicoside, the active ingredient in Miorel, is a muscle relaxant presented as an injectable solution for intramuscular use. It is employed to relieve muscle spasm and associated musculoskeletal pain, primarily in adult patients.

GNH India supplies Miorel as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide. The product conforms to EU quality standards and is distributed under strict regulatory oversight.

Manufacturer / TM Owner

Laboratorio Farmaceutico S.I.T. S.R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Thiocolchicoside is indicated for conditions involving skeletal muscle spasm and related pain, often in acute or sub‑acute settings.

  • Muscle spasm: provides rapid relief of involuntary muscle contraction and associated discomfort.
  • Acute low back pain: helps reduce pain and improve functional mobility during short‑term episodes.
  • Musculoskeletal pain: alleviates pain linked to muscle strain or injury, supporting recovery.

How It Works

  • Thiocolchicoside acts as an antagonist of glycine receptors in the spinal cord and brainstem, reducing inhibitory neurotransmission. This blockade diminishes neuronal firing that sustains muscle tone, leading to relaxation of skeletal muscles. The drug also modulates other ion channels, contributing to its overall antispasmodic effect without directly affecting the central nervous system.

Side Effects

Adverse reactions may occur with intramuscular administration of thiocolchicoside.

Common Side Effects

  • Injection site pain: mild to moderate discomfort at the injection site.
  • Nausea: transient feeling of queasiness.
  • Dizziness: occasional light‑headed sensation.
  • Headache: mild to moderate intensity.
  • Fatigue: general feeling of tiredness.
  • Mild skin rash: limited erythema or itching.

Serious or Rare Side Effects

  • Anaphylaxis: severe allergic reaction with breathing difficulty.
  • Hepatotoxicity: signs of liver injury such as jaundice.
  • Severe hypotension: marked drop in blood pressure.
  • Seizures: rare occurrence of convulsive episodes.
  • Agranulocytosis: dangerously low white‑blood‑cell count.
  • Stevens‑Johnson syndrome: severe skin and mucous membrane reaction.

Precautions & Warnings

Before using thiocolchicoside, consider the following safety measures.

  • Pregnancy: safety not established; avoid unless benefits outweigh risks.
  • Breastfeeding: unknown excretion; use with caution.
  • Elderly patients: monitor for increased sensitivity to muscle relaxation.
  • Renal or hepatic impairment: dose adjustment may be required.
  • Concomitant CNS depressants: assess for additive sedation.
  • Store at 2-8°C: keep refrigerated, protect from light, do not freeze.

Avoid Interactions

Thiocolchicoside may interact with several drug classes; review patient medication lists.

Major Interactions (Avoid)

  • Neuromuscular blocking agents: may potentiate muscle weakness.
  • CNS depressants (e.g., benzodiazepines): risk of excessive sedation.

Moderate Interactions (Monitor Closely)

  • Antihistamines: possible additive drowsiness.
  • Antiepileptic drugs: may alter seizure threshold.
  • CYP450 inhibitors: potential increase in plasma levels.
  • Diuretics: monitor electrolyte balance.
  • Anticoagulants: observe for bleeding at injection site.

Frequently Asked Questions

Miorel, containing thiocolchicoside, is prescribed to treat muscle spasm and related musculoskeletal pain. It is commonly used in acute low‑back pain, muscle strain, and other situations where involuntary muscle contraction contributes to discomfort.

Thiocolchicoside blocks glycine receptors in the central nervous system, reducing inhibitory neurotransmission that maintains muscle tone. This antagonism leads to decreased neuronal activity and results in relaxation of skeletal muscles, helping to alleviate spasm and pain.

The dosage of Miorel is determined by the prescribing clinician based on the patient’s condition, age, weight, and response to therapy. Healthcare professionals set the appropriate amount and frequency according to current medical guidelines.

Safety data for thiocolchicoside in pregnancy and lactation are limited. It is generally advised to avoid use unless the potential benefit justifies the possible risk to the fetus or infant, and the decision should be made by a qualified healthcare provider.

To request Miorel, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Compared with traditional centrally acting muscle relaxants, thiocolchicoside has a distinct mechanism as a glycine‑receptor antagonist, offering targeted spasm relief with a different side‑effect profile. Clinicians may choose it when a non‑sedating option is preferred, but individual response and safety considerations guide selection.

Miorel should be stored at 2‑8 °C, kept refrigerated, protected from light, and must not be frozen or shaken. Maintaining the cold chain preserves the stability and potency of the injectable formulation.

Miorel is supplied as an injectable solution for intramuscular injection. A qualified healthcare professional administers the dose into a muscle, typically the gluteal or deltoid region, following aseptic technique and the prescriber’s instructions.

Serious adverse events, although rare, include anaphylactic reactions, severe hypotension, hepatotoxicity, agranulocytosis, seizures, and Stevens‑Johnson syndrome. Patients should be monitored for any signs of these conditions, and immediate medical attention is required if they occur.

Miorel is contraindicated in patients with known hypersensitivity to thiocolchicoside or any excipients, and it should be avoided in individuals with severe hepatic or renal impairment unless specifically advised by a physician. Caution is also warranted in pregnant or breastfeeding women when safer alternatives exist.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Thiocolchicoside

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT